Fred E. Cohen

Biography

Dr. Cohen has served as a member of our Board since May 2002. In 2001, Dr. Cohen joined TPG Capital, a private investment firm, to initiate and lead TPG’s venture efforts in biotechnology and life sciences as a Partner and Managing Director. He retired from this role at TPG at the end of 2016 and now serves as a Senior Advisor to TPG. Beginning is 1986, and until his retirement in 2016, Dr. Cohen also served as a member of the faculty of University of California, San Francisco (UCSF). Dr. Cohen is a member of the boards of directors of BioCryst Pharmaceuticals, Inc., CareDx, Inc., Genomic Health, Inc., Roka BioScience, Inc., Tandem Diabetes Care, Inc., UroGen Pharma Ltd, and Veracyte, Inc., each of which is a public company. Dr. Cohen previously served as a member of the board of directors of Quintiles Transnational Holdings, Inc., which was a public company during Dr. Cohen’s service as a director. He is a member of the National Academy of Medicine and the American Academy of Arts and Sciences. Dr. Cohen received a B.S. degree in Molecular Biophysics and Biochemistry from Yale University, a D.Phil. degree in Molecular Biophysics from Oxford University, where he was a Rhodes Scholar, and an M.D. degree from Stanford University.

Research Interest

Dr. Cohen has served as a member of our Board since May 2002. In 2001, Dr. Cohen joined TPG Capital, a private investment firm, to initiate and lead TPG’s venture efforts in biotechnology and life sciences as a Partner and Managing Director. He retired from this role at TPG at the end of 2016 and now serves as a Senior Advisor to TPG. Beginning is 1986, and until his retirement in 2016, Dr. Cohen also served as a member of the faculty of University of California, San Francisco (UCSF). Dr. Cohen is a member of the boards of directors of BioCryst Pharmaceuticals, Inc., CareDx, Inc., Genomic Health, Inc., Roka BioScience, Inc., Tandem Diabetes Care, Inc., UroGen Pharma Ltd, and Veracyte, Inc., each of which is a public company. Dr. Cohen previously served as a member of the board of directors of Quintiles Transnational Holdings, Inc., which was a public company during Dr. Cohen’s service as a director. He is a member of the National Academy of Medicine and the American Academy of Arts and Sciences. Dr. Cohen received a B.S. degree in Molecular Biophysics and Biochemistry from Yale University, a D.Phil. degree in Molecular Biophysics from Oxford University, where he was a Rhodes Scholar, and an M.D. degree from Stanford University.